Schedule 13G ownership disclosure
INFINITY PHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45665G303
Event date: 2015-01-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-15-008924
- Form type
- SC 13G
- Filer
- BB BIOTECH AG
- CIK
- CIK 924223
- Filed
- Jan 13, 2015
- Reporting period
- Jan 08, 2015
- Description
- Schedule 13G beneficial ownership